Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The future of pathology in gastroenterology and hepatology

Pathology is a fast-changing discipline, owing to developments in high-throughput molecular technologies and artificial intelligence. In this Comment, I discuss how these advances will shape the future of gastrointestinal and liver pathology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. van den Tweel, J. G. & Taylor, C. R. A brief history of pathology: preface to a forthcoming series that highlights milestones in the evolution of pathology as a discipline. Virchows Arch. 457, 3–10 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nakane, P. K. & Pierce, G. B. Jr. Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens. J. Cell Biol. 33, 307–318 (1967).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Moffitt, J. R., Lundberg, E. & Heyn, H. The emerging landscape of spatial profiling technologies. Nat. Rev. Genet. 23, 741–759 (2022).

    Article  CAS  PubMed  Google Scholar 

  4. Frei, A. L. et al. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. Lancet Oncol. 25, 198–211 (2024).

    Article  PubMed  Google Scholar 

  5. Jia, G. et al. Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature 640, 1031–1041 (2025).

    Article  CAS  PubMed  Google Scholar 

  6. Foersch, S. et al. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat. Med. 29, 430–439 (2023).

    Article  CAS  PubMed  Google Scholar 

  7. Zeng, Q. et al. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. Lancet Oncol. 24, 1411–1422 (2023).

    Article  CAS  PubMed  Google Scholar 

  8. Saillard, C. et al. Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides. Hepatology 72, 2000–2013 (2020).

    Article  PubMed  Google Scholar 

  9. Echle, A. et al. Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning. Gastroenterology 159, 1406–1416.e11 (2020).

    Article  CAS  PubMed  Google Scholar 

  10. Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer. Roche https://www.roche.com/media/releases/med-cor-2025-04-29 (2025).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julien Calderaro.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calderaro, J. The future of pathology in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 22, 598–599 (2025). https://doi.org/10.1038/s41575-025-01103-6

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41575-025-01103-6

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing